Parinaud syndrome

Parinaud syndrome also known as Sylvian aqueduct syndrome, dorsal midbrain syndrome, pretectal syndrome, and Koerber-Salus-Elschnig syndrome is a cluster of abnormalities of eye movements and pupil dysfunction, characterized by ¹:

1. Paralysis of upgaze: Downward gaze is usually preserved. This vertical palsy is supranuclear, so doll’s head maneuver should elevate the eyes, but eventually all upward gaze mechanisms fail.
2. Pseudo-Argyll Robertson pupils: Accommodative paresis ensues, and pupils become mid-dilated and show light-near dissociation.
3. Convergence-Retraction nystagmus: Attemps at upward gaze often produce this phenomenon. On fast up-gaze, the eyes pull in and the globes retract. The easiest way to bring out this reaction is to ask the patient to follow down-going stripes on an optokinetic drum.
4. Eyelid retraction (Collier’s sign)
5. Conjugate down gaze in the primary position: “setting-sun sign”. Neurosurgeons will often see this sign most commonly in patients with failed ventriculoperitoneal shunts.

The original description by Henri Parinaud included upgaze palsy and convergence paralysis. The classic triad of upgaze paly, convergence retraction nystagmus and pupillary light-near dissociation was seen in about 65% of patients with Parinaud’s syndrome. However, the definition of Parinaud syndrome has now been widened to include the triad of upgaze paralysis, convergence retraction nystagmus, and pupillary light-near dissociation. Also, it may sometimes include conjugate downgaze in primary position and rarely downgaze palsy ².

The characteristic symptom of Parinaud syndrome is limited conjugate upgaze. It occurs because of the involvement of the vertical gaze centers, which are in proximity to the superior colliculus, with some of the main nuclei being the interstitial nuclei of Cajal and the rostral interstitial nucleus of the Medial Longitudinal Fasciculus. Downgaze is classically preserved, but the reason for this is not entirely explained. It has been suggested that the pathways for downward gaze are directed medially from the rostral interstitial nucleus of the Medial Longitudinal Fasciculus; whereas, the fibers for upward gaze are directed laterally from the Medial Longitudinal Fasciculus and decussate in the posterior commissure. This makes them more susceptible to the pressure effect of space occupying lesions. However, a condition called Reverse Parinaud syndrome has also been described. In this condition, there is downgaze palsy instead of upgaze palsy, and the patient presents with the combination of downgaze palsy with convergence weakness and pupillary light-near dissociation. This is an extremely rare condition with very few reported cases.

Another component of the triad of Parinaud syndrome is convergence- retraction nystagmus which is characterized by an irregular, jerky nystagmus, associated with convergence and retraction of both eyes, especially on attempted upgaze. It has been postulated that convergence retraction nystagmus is caused by damage to the supranuclear fibers, which have an inhibitory effect on the midbrain convergence or divergence neurons. This results in sustained discharge from the medial rectus and other extraocular muscles. Convergence retraction nystagmus is considered a highly localizing sign, pointing to a lesion of the dorsal midbrain.

The third component of the Parinaud syndrome triad is pupillary involvement. There is poor pupillary constriction to light but preserved constriction with convergence. The pupillary light reflex fibers synapse at the pretectal nucleus and the pass to the Edinger-Westphal nucleus of the same side and the contralateral side through the posterior commissure, making them susceptible to external compressive effects of mass lesions. It is thought that the fibers for the near reflex are located more ventrally. Thus they are spared in Parinaud syndrome, which is a dorsal midbrain syndrome.

Patients may also present with lid retraction in the primary position, which is called the Collier sign. The cause is thought to be due to damage to the levator inhibitory fibers at the posterior commissure.

Parinaud syndrome is also commonly associated with bilateral papilledema. It has less commonly been associated with spasm of accommodation on attempted upward gaze, pseudoabducens palsy (also known as thalamic esotropia) or slower movements of the abducting eye than the adducting eye during horizontal saccades, see-saw nystagmus and associated ocular motility deficits including skew deviation, oculomotor nerve palsy, trochlear nerve palsy and internuclear ophthalmoplegia.

Parinaud’s syndrome usually presents as a sporadic condition. The most common causes are pineal gland tumors and midbrain infarction ³. Some studies have described that up to 65% of cases are due to primary midbrain lesions like strokes, hemorrhages, and neoplasms and up to 30% of cases were due to pineal gland tumors causing pressure on the reflex centers in the quadrigemina dorsal midbrain ⁴.

Parinaud syndrome causes

The causes of Parinaud syndrome include pineal gland tumors, midbrain infarctions, multiple sclerosis, midbrain hemorrhage, encephalitis, cerebral arteriovenous malformations, brainstem infections (toxoplasmosis), trauma, obstructive hydrocephalus, and sometimes, tonic-clonic seizures. There have been reports of Parinaud syndrome following brachytherapy instillation. However, the most common causes are a pineal gland tumor and other midbrain pathologies like hemorrhage and infarction ¹. The underlying cause of Parinaud syndrome is also found to vary with age. Neoplastic causes are more common in children and young adults, and vascular causes are more common in the middle-aged and older populations.

Classically, Parinaud syndrome has been associated with 3 major groups:

1. Young patients with brain tumors in the Pineal Gland or midbrain: Pinealomas are the most common lesion producing this syndrome.
2. Women in their 20s-30s with Multiple Sclerosis
3. Older patients following stroke of the upper brainstem

Vertical supranuclear ophthalmoplegia has also been associated with metabolic disorders, such as Niemaann-Pick disease, Wilson’s disease, kernicterus, and barbiturate overdose.

Parinaud’s syndrome signs and symptoms result from injury, either direct or compressive, to the rostral midbrain. Specifically, compression or ischemic damage of the superior colliculus within the mesencephalon, where the nucleus of the oculomotor nerve (cranial nerve III) and the Edinger-Westphal nucleus are located, cause dysfunction to the motor function of the eye.

Parinaud syndrome symptoms

Parinaud syndrome is classically described by the triad of upgaze palsy, convergence retraction nystagmus, and pupillary hyporeflexia ⁵. Patients may complain of difficulty looking up, blurred near vision, diplopia, oscillopsia, and there may be associated neurological symptoms. Many studies have described diplopia as the most common symptom. It is seen in 65% of patients. Diplopia may be caused either by skew deviation or associated fourth nerve palsy. Vertical diplopia is classically seen and can be very disabling to the patient. Some patients may also a complaint of blurred vision, and it could be due to accommodation spasm. For many, the most incapacitating symptom is the inability to elevate the eyes, often causing a compensatory chin up position.

The signs of Parinaud syndrome include:

• Paralysis of vertical gaze, especially conjugate upgaze palsy. Sometimes there may be combined upgaze and downgaze palsy, and rarely there could be only downgaze palsy. The vestibule-ocular reflex is classically spared
• Convergence retraction nystagmus, which is best elicited using a downwardly moving optokinetic nystagmus drum ⁶. Attempted up-gaze triggers an episodic refractory jerking of the eyes
• Loss of pupillary light reflexes (Light Near-dissociation)
• Loss of convergence is seen in less than a quarter of patients
• Upper eyelid retraction (Collier’s “tucked lid” sign) seen in approximately 40% of patients
• There could be a conjugate downgaze in the primary position, called the “setting sun” sign

Parinaud syndrome diagnosis

A thorough neurological examination is indicated in all patients. Visual acuity examination, visual fields, color vision, pupillary examination, and fundoscopy are indicated. Because of the wide variety of causes of this condition, a thorough workup including neuroimaging is mandatory to discover the underlying cause ⁷. Infection screening, serum protein electrophoresis, and thyroid function tests may also be done. Other investigations which may be done include cerebrospinal fluid studies, serum acetylcholine receptor antibodies, and nerve conduction studies.

Parinaud syndrome treatment

Treatment is primarily directed toward the underlying cause. Symptoms may be completely reversed in patients with early hydrocephalus. The aim of treatment is, therefore, to treat the underlying condition urgently before permanent damage occurs ⁸. Persistent upgaze palsies may be corrected surgically. The surgical options include inferior rectus recession, superior rectus resection, and superior transposition of medial and lateral rectus muscles. All these procedures improve upgaze position and abnormal head position and ultimately improve the severity of retraction nystagmus. Visual training and tracking exercises are another options, which can also be used in patients with persistent gaze palsies.

Parinaud syndrome prognosis

The outcomes for patients with Parinaud syndrome depend on the cause.

References

1. Feroze KB, Patel BC. Parinaud Syndrome. [Updated 2019 Jun 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441892
2. Keane JR. The pretectal syndrome: 206 patients. Neurology. 1990 Apr;40(4):684-90.
3. Burgueño-Montañés C, Santalla-Castro C, Peña-Suárez J. Parinaud «plus» syndrome in a patient with dysgerminoma. Arch Soc Esp Oftalmol. 2016 Jul;91(7):341-5.
4. Cheung T, Proulx A, Fraser JA. Primary central nervous system lymphoma presenting as Parinaud syndrome. Can. J. Ophthalmol. 2011 Oct;46(5):445-6.
5. Shields M, Sinkar S, Chan W, Crompton J. Parinaud syndrome: a 25-year (1991-2016) review of 40 consecutive adult cases. Acta Ophthalmol. 2017 Dec;95(8):e792-e793.
6. Crawford AH, Beltran E, Lam R, Kenny PJ. Convergence-Retraction Nystagmus Associated with Dorsal Midbrain Lesions in Three Dogs. J. Vet. Intern. Med. 2016 Jul;30(4):1229-34.
7. Swinkin E, Bui E. Teaching NeuroImages: Acute Parinaud syndrome. Neurology. 2017 Apr 18;88(16):e164-e165.
8. Hankinson EV, Lyons CJ, Hukin J, Cochrane DD. Ophthalmological outcomes of patients treated for pineal region tumors. J Neurosurg Pediatr. 2016 May;17(5):558-63.